🇺🇸 FDA
Company

C4

C4 Therapeutics

CCCC biotech USA

Quick answer

C4 is a biotech company (CCCC) headquartered in WATERTOWN, MA, USA with 4 tracked pipeline programs.

Pipeline (4)

project

cemsidomide

Multiple Myeloma

Phase 2 · small_molecule · active

2 trials project

CFT1946

Solid Tumors

Phase 1 · small_molecule · completed

1 trials project

CFT8634

Synovial Sarcoma

Phase 1 · small_molecule · terminated

1 trials project

Cemsidomide

Multiple Myeloma (MM)

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 12421220

Bicyclic-substituted glutarimide cereblon binders

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12371442

Isoindolinone and indazole compounds for the degradation of EGFR

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12227504

Spirocyclic compounds

Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12180225

N/O-linked degrons and degronimers for protein degradation

Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12157735

Compounds for targeted degradation of BRD9

Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12091397

Dihydroquinolinones for medical treatment

Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12076405

Heterocyclic degronimers for target protein degradation

Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12048748

Spirocyclic degronimers for target protein degradation

Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)